Ketilept Prolong (Quetiapine Fumarate)

Quetiapine fumarate works by blocking serotonin 5‑HT2A and dopamine D2 receptors while partially stimulating 5‑HT1A receptors. This combination reduces psychotic symptoms, balances mood, and can improve depressive symptoms by modulating neurotransmitter activity in the brain.

The appropriate dose of Ketilept Prolong is determined individually by a qualified prescriber based on the patient’s diagnosis, severity of symptoms, response to therapy and tolerability. No fixed regimen is provided here; clinicians should follow local prescribing guidelines.

Safety data for quetiapine fumarate in pregnancy and lactation are limited. The prescriber must weigh potential benefits against possible risks to the fetus or infant. If treatment is essential, it may be continued under close medical supervision, but alternative therapies are considered when possible.

To order Ketilept Prolong, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketilept Prolong (quetiapine) offers a broad receptor profile that provides both antipsychotic and mood‑stabilising effects, often with a lower risk of extrapyramidal symptoms compared with some older agents. Compared with risperidone or olanzapine, quetiapine may cause more sedation and weight gain but is frequently chosen for its efficacy in bipolar depression and as an adjunct in major depressive disorder.

Ketilept Prolong should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Ketilept Prolong is taken orally, usually as a whole tablet swallowed with water. It may be taken with or without food, but consistent administration with respect to meals can help maintain stable blood levels. Patients should follow the prescriber’s instructions regarding timing and any dose adjustments.

Serious risks include neuroleptic malignant syndrome, agranulocytosis, significant QT interval prolongation leading to arrhythmias, severe hypotension, and suicidal thoughts, especially during early treatment or dose changes. Patients should seek immediate medical attention if they experience high fever, muscle rigidity, unexplained bruising, palpitations, or worsening depression.

Ketilept Prolong is contraindicated in individuals with known hypersensitivity to quetiapine or any of its excipients, and in patients with uncontrolled narrow‑angle glaucoma. Caution is advised for those with severe cardiovascular disease, hepatic impairment, or a history of seizures. Pregnant or breastfeeding women should only use it if the potential benefit justifies the risk.